Form 8-K - Current report:
SEC Accession No. 0001641172-25-024732
Filing Date
2025-08-19
Accepted
2025-08-19 08:00:23
Documents
36
Period of Report
2025-08-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38750
2 EX-99.1 ex99-1.htm EX-99.1 14893
3 GRAPHIC ex99-1_001.jpg GRAPHIC 171358
4 GRAPHIC ex99-1_002.jpg GRAPHIC 376261
5 GRAPHIC ex99-1_003.jpg GRAPHIC 159507
6 GRAPHIC ex99-1_004.jpg GRAPHIC 164694
7 GRAPHIC ex99-1_005.jpg GRAPHIC 128711
8 GRAPHIC ex99-1_006.jpg GRAPHIC 198482
9 GRAPHIC ex99-1_007.jpg GRAPHIC 203189
10 GRAPHIC ex99-1_008.jpg GRAPHIC 179429
11 GRAPHIC ex99-1_009.jpg GRAPHIC 206434
12 GRAPHIC ex99-1_010.jpg GRAPHIC 853844
13 GRAPHIC ex99-1_011.jpg GRAPHIC 212518
14 GRAPHIC ex99-1_012.jpg GRAPHIC 149251
15 GRAPHIC ex99-1_013.jpg GRAPHIC 204007
16 GRAPHIC ex99-1_014.jpg GRAPHIC 184269
17 GRAPHIC ex99-1_015.jpg GRAPHIC 176497
18 GRAPHIC ex99-1_016.jpg GRAPHIC 177554
19 GRAPHIC ex99-1_017.jpg GRAPHIC 152825
20 GRAPHIC ex99-1_018.jpg GRAPHIC 217469
21 GRAPHIC ex99-1_019.jpg GRAPHIC 797222
22 GRAPHIC ex99-1_020.jpg GRAPHIC 118811
23 GRAPHIC ex99-1_021.jpg GRAPHIC 207122
24 GRAPHIC ex99-1_022.jpg GRAPHIC 177213
  Complete submission text file 0001641172-25-024732.txt   7721601

Data Files

Seq Description Document Type Size
25 XBRL SCHEMA FILE aktx-20250819.xsd EX-101.SCH 3810
26 XBRL DEFINITION FILE aktx-20250819_def.xml EX-101.DEF 26684
27 XBRL LABEL FILE aktx-20250819_lab.xml EX-101.LAB 36827
28 XBRL PRESENTATION FILE aktx-20250819_pre.xml EX-101.PRE 25308
38 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5374
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 251229679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)